polatuzumab vedotin
roche
['polatuzumab', ' vedo', 'dlbcl', 'lymsm', 'pola']
polatuzumab vedotin substitution in r-mini-chop does not worsen high-grade toxicities in dlbcl #eha2023 #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.